Therapeutic class — broad (HIC1)Skin/Subcutaneous Tissue
HIC2 codeL8
Therapeutic class — intermediate (HIC2)Deodorants And Antiperspirants
HIC3 codeL8B
Therapeutic class — specific (HIC3)Antiperspirants
AHFS code84:12.00.00
AHFS classAstringents (84:12)
FDB label nameXERAC AC 6.25% SOLUTION
FDB brand nameXerac Ac
Legend statusO — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 0096-0709-35 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00096-0709-35. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️RxNorm drug class
This medicine belongs to the Other anti-acne preparations for topical use class.
Drug family (ATC)Other anti-acne preparations for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name XERAC AC 6.25% SOLUTIONIngredient Aluminum Chloride
🧪 What is this product?
Xerac AC is a topical liquid containing aluminum chloride, an ingredient commonly used in over-the-counter antiperspirant products. Aluminum chloride functions as an astringent and antiperspirant agent, typically applied to the skin to help reduce sweating. This product is marketed as an OTC monograph drug, meaning it follows FDA's established safety and effectiveness standards for this class of products rather than undergoing individual application review.
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Xerac AC?
Ask a licensed pharmacist directly — free, answered by our team.
Inactive ingredients, also called excipients, are components of the drug product
other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors,
or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
1 inactive ingredient listed in the exact product block matched to this NDC.
The official label also statesAnhydrous ethanol
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
Price system
Per mL
Per package
Retail pharmacies payNADAC · weekly
$0.217
—
Medicaid paysCMS SDUD · 12 mo
$0.3671
—
Medicare drug plans payPart D · quarterly
No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
▲ Up 3% over the last 9 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
1996
On the market since
Jun 1996
📍
2026
Currently FDA-listed
30 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🗺️ Medicaid utilization & spend
📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for 00096-0709-35, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
696
Units reimbursed last 4 qtrs
26.4K
Gross reimbursed last 4 qtrs
$9.7K
Avg / prescription
$13.93
Avg / unit
$0.3671
Latest quarter Q4 2025
148Rx
Medicaid pays / mL
$0.3671
gross reimbursed
vs
NADAC / mL
$0.2173
acquisition cost
=
Spread
+$0.1498
+69% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
71% FFS29% MCO
Fee-for-service · 497 Rx Managed care · 199 Rx
State Medicaid map
Units reimbursed · per 100k residents
8.3135
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
Prescriptions—
Units—
Reimbursed—
🏆 Top states by units · per 100k residents
1Vermont135 /100k
2Iowa88.4 /100k
3New York79.0 /100k
4Maine70.3 /100k
5Rhode Island44.7 /100k
6New Jersey31.3 /100k
7West Virginia21.8 /100k
8Minnesota12.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
💊 Medicaid utilization by pack size
Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
Per mL, this pack runs about 26% above the cheapest pack (49.86 g in 1 PACKAGE (00, $0.1718 vs $0.2173 NADAC).
This pack accounts for about 40% of this product's recent Medicaid fills; most go to the 49 gs pack. See all packs ↓
Pack size FAQ
What quantity is in NDC 00096-0709-35?
NDC 00096-0709-35 contains 29.09 g — 29.09 g in 1 package.
What is the difference between NDC 00096-0709-35 and NDC 00096-0709-60?
Both are Xerac AC .0625 g/g Liquid — the drug itself is identical. NDC 00096-0709-35 is the 29.09 g package, while NDC 00096-0709-60 is the 49.86 g package. Per-mL NADAC also differs: $0.2173 here vs $0.1718 for the 49.86 g pack.
What NDC number is used to bill for this package of Xerac AC .0625 g/g Liquid?
Bill NDC 00096-0709-35 — the 11-digit billing format is 00096070935. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
Indicatins and Usage Section For patients suffering from hyperhidrosis, or patients whose jobs or sports activities cause excessive sweating that exacerbates other skin problems.
⏱️Dosage and Administration100 words▾
DOSAGE & ADMINISTRATION SECTION Xerac AC when applied to the underarms, should be applied to absolutely dry skin. Only apply Xerac AC before bedtime, since medication should be kept on the skin for 6-8 hours. To reduce irritation, let the alcohol evaporate, leaving a thin film of antiperspirant on the skin.
Wear a T-shirt, while sleeping to prevent medication from being rubbed off on the bed linens. Do not apply Xerac AC to broken, irritated or recently shaved skin. Wash the treated area next morning with soap and water.
Do not apply other deodorants or antiperspirants while using Xerac AC.
⚠️Warnings40 words▾
WARNINGS SECTION For external use only. Avoid contact with eyes. If contact occurs, wash eyes thoroughly with water. If irritation or sensitization occurs, discontinue use or contact a physician. Xerac AC may be harmful to cotton fibers and certain metals.
🧪Active Ingredient8 words▾
OTC - ACTIVE INGREDIENT SECTION Aluminum Chloride Hexahydrate
🧪Inactive Ingredients5 words▾
INACTIVE INGREDIENT SECTION Anhydrous ethanol
🎯Purpose11 words▾
OTC - PURPOSE SECTION For topical application as an antiperspirant (anhidrotic).
No label section mentions that — try another word, or open the full label on DailyMed below.
Glossary — plain-language definitions of medical terms used in this label:
Active ingredient: The part of a medicine that produces its intended effect on the body.
Inactive ingredient: A component of a medicine, such as a filler, binder, or dye, that does not produce the intended effect.
topical: Applied onto the skin, eyes, or another body surface to work mainly where it is placed.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.
